InvestorsHub Logo
Followers 17
Posts 10892
Boards Moderated 0
Alias Born 03/11/2017

Re: None

Sunday, 11/25/2018 2:37:51 PM

Sunday, November 25, 2018 2:37:51 PM

Post# of 44784
According To Page 27 Of The November Company Presentation, They Are Definitely Going It Alone And Only Have Plans To License Out Indications With Large Patient Populations Like CLI. However, With The Recent/Incredible HbAlc Data From The IC Trial. The Possibility Of An Out-Licensing Deal For Diabetes Just Sky-Rocked ! Hello Novo Nordisk Or Eli Lilly ???


http://www.pluristem.com/wp-content/uploads/2016/04/Pluristem-November-2018_website-2.pdf